Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Caitlin E. Cox

July 11, 2024

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

Aspirin Not Protective Against CVD in Black Patients

Caitlin E. Cox

December 18, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Daily News

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

Michael O'Riordan

May 20, 2019

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

Advertisement

August 2025 Dispatch for the CV Team

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

November 2024 Dispatch for the CV Team

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Statins Not Linked to Dementia or Memory Changes: ASPREE

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Aspirin Not Protective Against CVD in Black Patients

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

Aspirin Should Play Limited Role in Primary Prevention: Review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content